These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20634295)

  • 1. Uremic cardiomyopathy and insulin resistance: a critical role for akt?
    Semple D; Smith K; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2011 Feb; 22(2):207-15. PubMed ID: 20634295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin.
    Semple DJ; Bhandari S; Seymour AM
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1275-86. PubMed ID: 22914780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
    Yu W; Chen C; Fu Y; Wang X; Wang W
    Cardiovasc Ther; 2010 Apr; 28(2):101-5. PubMed ID: 20398099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uremic cardiomyopathy].
    Drüeke T
    Med Klin; 1981 Sep; 76(20):560-2. PubMed ID: 6212758
    [No Abstract]   [Full Text] [Related]  

  • 5. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiomyopathy in uremia: hemodynamic and metabolic aspects (author's transl)].
    Drüeke T; Le Pailleur C
    Nephrologie; 1981; 2(2):63-6. PubMed ID: 7290302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in chronic uremia.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R
    J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear targeting of Akt enhances ventricular function and myocyte contractility.
    Rota M; Boni A; Urbanek K; Padin-Iruegas ME; Kajstura TJ; Fiore G; Kubo H; Sonnenblick EH; Musso E; Houser SR; Leri A; Sussman MA; Anversa P
    Circ Res; 2005 Dec; 97(12):1332-41. PubMed ID: 16293788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.
    Kennedy DJ; Vetteth S; Periyasamy SM; Kanj M; Fedorova L; Khouri S; Kahaleh MB; Xie Z; Malhotra D; Kolodkin NI; Lakatta EG; Fedorova OV; Bagrov AY; Shapiro JI
    Hypertension; 2006 Mar; 47(3):488-95. PubMed ID: 16446397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy.
    Krüger M; Babicz K; von Frieling-Salewsky M; Linke WA
    J Mol Cell Cardiol; 2010 May; 48(5):910-6. PubMed ID: 20184888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
    Aksentijević D; Bhandari S; Seymour AM
    Kidney Int; 2009 Apr; 75(7):711-8. PubMed ID: 19177156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling.
    Li R; Zhang H; Wang W; Wang X; Huang Y; Huang C; Gao F
    Eur J Pharmacol; 2010 Feb; 628(1-3):140-7. PubMed ID: 19944677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
    Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B
    Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.
    Gross ML; Ritz E
    Semin Dial; 2008; 21(4):308-18. PubMed ID: 18627569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of impaired calcium homeostasis in the development of cardiac hypertrophy].
    Kieć-Wilk B; Petkow-Dimitrow P; Kwaśniak M; Dembińska-Kieć A
    Kardiol Pol; 2009 Dec; 67(12):1396-402. PubMed ID: 20054774
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.
    Shiojima I; Walsh K
    Genes Dev; 2006 Dec; 20(24):3347-65. PubMed ID: 17182864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway.
    Liang CS; Mao W; Liu J
    Autoimmunity; 2008 Sep; 41(6):434-41. PubMed ID: 18781469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.
    Wang X; Liu J; Drummond CA; Shapiro JI
    Expert Opin Ther Targets; 2017 May; 21(5):531-541. PubMed ID: 28338377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.